Blood Transfusion Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Global Blood Transfusion Diagnostics Market Trends and it is segmented by Product Type (Instruments and Reagents & Kits), Application (Blood Grouping and Disease Screening), End User (Hospitals, Diagnostics Laboratories, Blood Banks, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market values are provided in terms of (USD million) for the above segments.

Blood Transfusion Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Blood Transfusion Diagnostics Industry Overview

The Blood Transfusion Diagnostics Market is consolidated in nature. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. The key players in the market include Grifols, S.A., F. Hoffmann-La Roche Ltd., Immucor, Inc., Bio-Rad Laboratories, Inc., Quotient Suisse SA, Merck KGaA, Abbott, Diasorin S.p.A, Danaher, and Werfen among others.

Blood Transfusion Diagnostics Market Leaders

  1. Grifols, S.A.

  2. F. Hoffmann-La Roche Ltd.

  3. Diasorin S.p.A

  4. Bio-Rad Laboratories, Inc.

  5. Quotient Suisse SA

  6. *Disclaimer: Major Players sorted in no particular order
Blood Transfusion Diagnostics Market Concentration

Blood Transfusion Diagnostics Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?